Cost-Effectiveness of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: a Critical Review.

about

Cost-Effectiveness of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: a Critical Review.

Item

http://www.wikidata.org/entity/Q39249966

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cost-Effectiveness of Stereota ...... on Therapy: a Critical Review.

@en

Cost-Effectiveness of Stereota ...... on Therapy: a Critical Review.

@nl

type

Item

label

Cost-Effectiveness of Stereota ...... on Therapy: a Critical Review.

@en

Cost-Effectiveness of Stereota ...... on Therapy: a Critical Review.

@nl

prefLabel

Cost-Effectiveness of Stereota ...... on Therapy: a Critical Review.

@en

Cost-Effectiveness of Stereota ...... on Therapy: a Critical Review.

@nl

P1476

Cost-Effectiveness of Stereota ...... on Therapy: a Critical Review.

@en

P2093

David J Sher

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults

Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial

Calibration methods used in cancer simulation models and suggested reporting guidelines

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.

Projections of the cost of cancer care in the United States: 2010-2020.

Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer.

Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer.

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.

P2888

s11912-017-0599-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-017-0599-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nataniel H Lester-Coll

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28421482

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy